Neurite extension andin vitro myelination within three-dimensional modified fibrin matrices
- 22 December 2004
- journal article
- research article
- Published by Wiley in Journal of Neurobiology
- Vol. 63 (1) , 1-14
- https://doi.org/10.1002/neu.20116
Abstract
The deposition of fibrin clots in vivo occurs after injury in the peripheral nervous system and their removal correlates with nerve regeneration. Fibrin clots provide a provisional matrix for invading cells, induce wound healing, and become proteolytically removed by regenerating tissue. Here, neurite extension and in vitro myelination were studied within three‐dimensional fibrin matrices that were covalently modified with the sixth Ig‐like domain of cell adhesion molecules L1 containing N‐terminal transglutaminase substrate sequences (TG‐L1Ig6) for covalent incorporation into fibrin matrices. TG‐L1Ig6 is a specific receptor for αvβ3‐integrin involved in neurite extension of PC12 cells and dorsal root ganglion neurons (DRGs). Neurite extension of PC12 cells depended on interactions between cell surface αvβ3 and RGD‐sites provided by TG‐L1Ig6. In addition, matrix properties such as fibrin crosslink density and matrix degradation by serine proteases were crucial. No involvement of matrix metalloproteinases was found. DRG neurite extension in native fibrin matrices was retarded as compared to neurite extension within L1Ig6‐modified and laminin‐1‐containing matrices. Moreover, myelinated structures were almost exclusively found in TG‐L1Ig6‐modified and laminin‐1‐containing matrices. These results indicate that potential use of three‐dimensional matrices in a biomaterials‐based healing device to induce and/or help in vivo nerve regeneration requires specific structural and biological signals. © 2004 Wiley Periodicals, Inc. J Neurobiol, 2005Keywords
This publication has 44 references indexed in Scilit:
- Mechanical properties, proteolytic degradability and biological modifications affect angiogenic process extension into native and modified fibrin matrices in vitroBiomaterials, 2005
- Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent ProcessesThe Journal of Experimental Medicine, 2002
- PC12 cells utilize the homophilic binding site of L1 for cell−cell adhesion but L1–αvβ3 interaction for neurite outgrowthJournal of Neurochemistry, 2001
- The roles of cell adhesion molecules on the formation of peripheral myelin.The Keio Journal of Medicine, 2001
- Matrix Metalloproteinases Collagenase-2, Macrophage Elastase, Collagenase-3, and Membrane Type 1-Matrix Metalloproteinase Impair Clotting by Degradation of Fibrinogen and Factor XIIPublished by Elsevier ,2000
- Myelin synthesis in the peripheral nervous systemProgress in Neurobiology, 2000
- Tissue Plasminogen Activator–Mediated Fibrinolysis Protects against Axonal Degeneration and Demyelination after Sciatic Nerve InjuryThe Journal of cell biology, 2000
- The Configuration of Fibrin Clots Determines Capillary Morphogenesis and Endothelial Cell MigrationMicrovascular Research, 1996
- Degradation of Cross-Linked Fibrin by Matrix Metalloproteinase 3 (Stromelysin 1): Hydrolysis of the γ Gly 404−Ala 405 Peptide BondBiochemistry, 1996
- Antibodies to the L1 adhesion molecule inhibit Schwann cell ensheathment of neurons in vitro.The Journal of cell biology, 1989